It wasn’t a new strategy that has helped Geisinger reduce ER visits and hospital admissions. In fact, it’s one of the oldest in the books, says David Feinberg, who talks about the reboot that is changing the game.
Combatting the opioid epidemic means addressing all aspects of it, including prevention, treatment, and recovery, according to a panel of CIOs who presented at the CHIME Advocacy Summit.
In an industry where costs are skyrocketing and desired outcomes aren’t being achieved, fostering innovation isn’t just important – it’s vital to our survival, says Karen Murphy of Geisinger.
The key tenet of innovation? Quantifiable outcomes, says Karen Murphy, who talks about how Geisinger is thinking outside the box to improve outcomes for patients with diabetes, and curb opioid abuse.
It isn’t a single “silver bullet” that’s going to help reduce the number of opioid-related deaths, but rather, a combination of IT tools that can identify prescribing patterns and education on alternative therapies, says Geisinger CIO John Kravitz.